Follitropin
- Generic Name
- Follitropin
- Brand Names
- Bemfola, Follistim, Gonal F, Gonal-F, Menopur, Ovaleap, Pergoveris, Puregon, GONAL-f, Rekovelle
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 146479-72-3
- Unique Ingredient Identifier
- 2M2GGL7HUP
- Background
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glyco...
- Indication
In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use...
- Associated Conditions
- -
- Associated Therapies
- Assisted Reproductive Technology therapy, Controlled Ovarian Stimulation
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- IVFarma LLC
- Target Recruit Count
- 5484
- Registration Number
- NCT04854707
- Locations
- 🇷🇺
Clinical Hospital "Mother and Child", Ufa, Russian Federation
🇷🇺Clinic "Mother and Child" Krasnodar, Krasnodar, Russian Federation
🇷🇺Clinic "Mather and Child" Lefortovo, Moscow, Russian Federation
Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 110
- Registration Number
- NCT04695483
- Locations
- 🇮🇹
Enrico Papaleo, Milan, Italy
Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 250
- Registration Number
- NCT04503707
- Locations
- 🇫🇷
Pierre OGER, Rueil-Malmaison, France
🇫🇷CHU Nantes Hôpital Hôtel Dieu, Nantes, France
🇫🇷Hôpital Femme Mère Enfant, BRON cedex, France
Effects of FSH on Endothelial Function (FEND)
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Federico II University
- Target Recruit Count
- 16
- Registration Number
- NCT04430621
- Locations
- 🇮🇹
Internal Medicine and Diabetes Unit, Napoli, Italy
FSH Followed by HMG vs FSH Plus HMG in IVF
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 530
- Registration Number
- NCT04385342
- Locations
- 🇪🇬
Fertility Care Unit (FCU) in Mansoura University Hospital, Mansourah, Dakahlia, Egypt
🇪🇬Department of Obstetrics and Gynecology, Alexandria, Egypt
🇪🇬RAHEM Fertility Centre, Zagazig, Egypt
Rekovelle PK Trial in Chinese Women
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT04150861
- Locations
- 🇨🇳
First Hospital Affiliated to Nanjing Medical University Jiangsu Province Hospital, Nanjing, China
Personalized Insemination Treatment Study
- Conditions
- Interventions
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Clinique Ovo
- Target Recruit Count
- 110
- Registration Number
- NCT03830723
- Locations
- 🇨🇦
Clinique Ovo, Montréal, Quebec, Canada
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 579
- Registration Number
- NCT03740737
- Locations
- 🇺🇸
Fertility Centers of Illinois (RH), Chicago, Illinois, United States
🇺🇸Seattle Reproductive Medicine WA, Seattle, Washington, United States
🇺🇸Women's Medical Research Group, LLC, Clearwater, Florida, United States
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 588
- Registration Number
- NCT03738618
- Locations
- 🇺🇸
Fertility Treatment Center, Tempe, Arizona, United States
🇺🇸Center for Reproductive Medicine, Winter Park, Florida, United States
🇺🇸Carolina Conceptions, Raleigh, North Carolina, United States
Hormone Evaluation in Artificial Reproductive Technology
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Lund University
- Target Recruit Count
- 796
- Registration Number
- NCT03737253
- Locations
- 🇸🇪
Reproductive Medicine Center, Malmö, Sweden
🇵🇱Poznan University of Medical Sciences, Poznań, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.